Table 1. Demographic of study population.
EOSIS | Control | P-value | ||
---|---|---|---|---|
(n = 20) | (n = 9) | |||
Age (Mean ± S.E.M.) | 32.5 ± 1.1 | 32.6 ± 2.0 | 0.48 | |
Race | Caucasian | 18 | 9 | 0.24 |
Hispanic | 1 | 0 | ||
Other/unspecified | 2 | 0 | ||
BMI (Mean ± S.E.M.) | 26.5 ± 1.5 | 28.1 ± 2.4 | 0.3 | |
Hormonal therapy | Yes | 10 | 5 | 0.9 |
No | 10 | 4 | ||
Disease Stage (r-ASRM* score) | Stage 1 (1–5) | 5 | N/A | N/A |
Stage 2 (6–15) | 3 | |||
Stage 3 (16–40) | 4 | |||
Stage 4 (>40) | 8 |
BMI: body mass index.
ASRM: American Society Reproductive Medicine.
P-values calculated using t test and chi-square test.